DBV Technologies (DBVT) Change in Inventory (2020 - 2026)
DBV Technologies (DBVT) reported Change in Inventory of $3.0 million for Q1 2026, down 30.23% year-over-year from $4.3 million in Q1 2025, and up 40.78% quarter-over-quarter from $2.1 million in Q4 2025.
DBV Technologies (DBVT) Change in Inventory (2020 - 2026) Analysis & Trends
DBV Technologies (DBVT) has 4 years of Change in Inventory data on file, last reported at $3.0 million in Q1 2026.
- Change in Inventory for Q1 2026 came in at $3.0 million, down 30.23% year-over-year; the trailing twelve-month figure through Mar 2026 was $14.8 million (up 235.58% YoY), and the FY2025 annual result was $16.1 million, up 1057.2% from the prior year.
- Change in Inventory improved to $3.0 million in Q1 2026 per DBVT's latest filing, from $2.1 million in the prior quarter.
- Over five years, Change in Inventory peaked at $6.0 million in Q2 2025 and troughed at $99000.0 in Q3 2024.
- A 3-year average of $2.9 million and a median of $3.0 million in 2026 frame the typical range for Change in Inventory.
- The sharpest annual moves came in 2025 and 2026: Change in Inventory soared 3617.17% in 2025, then sank 30.23% in 2026.
- A 3-year view of Change in Inventory shows it stood at $99000.0 in 2024, then soared by 2052.53% to $2.1 million in 2025, then jumped by 40.78% to $3.0 million in 2026.
- Business Quant data shows DBVT's Change in Inventory at $3.0 million in Q1 2026, $2.1 million in Q4 2025, and $3.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 51,468.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 97.70 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | DBV Technologies | 6.63 Bn | 6.41 Bn | -3.90 Mn | 3.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.00 Mn |
| Mar 31, 2026 | 3.00 Mn |
| Dec 31, 2025 | 2.13 Mn |
| Dec 31, 2025 | 2.13 Mn |
| Sep 30, 2025 | 3.68 Mn |
| Sep 30, 2025 | 3.68 Mn |
| Jun 30, 2025 | 5.95 Mn |
| Jun 30, 2025 | 5.95 Mn |
| Mar 31, 2025 | 4.30 Mn |
| Mar 31, 2025 | 4.30 Mn |
| Sep 30, 2024 | 99,000.00 |
| Sep 30, 2024 | 99,000.00 |
| Mar 31, 2024 | 1.29 Mn |
| Mar 31, 2024 | 1.29 Mn |
| Dec 31, 2020 | -35,000.00 |
| Dec 31, 2020 | -35,000.00 |
| Sep 30, 2020 | -3.73 Mn |
| Sep 30, 2020 | -3.73 Mn |
| Jun 30, 2020 | -969,000.00 |
| Jun 30, 2020 | -969,000.00 |